Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

A genome-wide association study on hematopoietic stem cell transplantation reveals novel genomic loci associated with transplant outcomes

Lookup NU author(s): Dr Rachel CrosslandORCiD, Professor Anne Dickinson

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Copyright © 2024 Rosenberger, Crossland, Dressel, Kube, Wolff, Wulf, Bickeböller, Dickinson and Holler.Introduction: Data on genomic susceptibility for adverse outcomes after hematopoietic stem cell transplantation (HSCT) for recipients are scarce. Methods: We performed a genome wide association study (GWAS) to identify genes associated with survival/mortality, relapse, and severe graft-versus-host disease (sGvHD), fitting proportional hazard and subdistributional models to data of n=1,392 recipients of European ancestry from three centres. Results: The single nucleotide polymorphism (SNP) rs17154454, intronic to the neuronal growth guidant semaphorin 3C gene (SEMA3C), was genome-wide significantly associated with event-free survival (p=7.0x10-8) and sGvHD (p=7.5x10-8). Further associations were detected for SNPs in the Paxillin gene (PXN) with death without prior relapse or sGvHD, as well as for SNPs of the Plasmacytoma Variant Translocation 1 gene (PVT1, a long non-coding RNA gene), the Melanocortin 5 Receptor (MC5R) gene and the WW Domain Containing Oxidoreductase gene (WWOX), all associated with the occurrence of sGvHD. Functional considerations support the observed associations. Discussion: Thus, new genes were identified, potentially influencing the outcome of HSCT.


Publication metadata

Author(s): Rosenberger A, Crossland RE, Dressel R, Kube D, Wolff D, Wulf G, Bickeboller H, Dickinson A, Holler E

Publication type: Article

Publication status: Published

Journal: Frontiers in Immunology

Year: 2024

Volume: 15

Online publication date: 07/02/2024

Acceptance date: 15/01/2024

Date deposited: 04/03/2024

ISSN (electronic): 1664-3224

Publisher: Frontiers Media SA

URL: https://doi.org/10.3389/fimmu.2024.1280876

DOI: 10.3389/fimmu.2024.1280876

Data Access Statement: The datasets presented in this article are not readily available because of legal and privacy restrictions. Requests to access the datasets should be directed to arosenb@gwdg.de.

PubMed id: 38384455


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Newcastle hospital charity BH191620

Share